Experts disagree on how doctors should reveal incidental findings in patients’ DNA sequences.
Experts disagree on how doctors should reveal incidental findings in patients’ DNA sequences.
James Watson files a brief in the ongoing legal case over Myriad Genetics’ right to hold patents on the BRCA1 and BRCA2 genes.
A new technique to derive DNA information from non-DNA sources, such as RNA, threatens the anonymity of genetic database donors.
The federal agency unveils a collection of thousands of genetic tests for some 2,500 diseases.
Fetal chromosomal microdeletions that can lead to developmental abnormalities are detectable in samples of the mother’s blood.
Last week researchers released the first non-invasive prenatal test for Down syndrome, and more such tests are expected in the coming months.
In addition to its relationship to a variety of diseases, the length ratio of the second and fourth fingers also correlates with stretched penile length in men.
The UK’s immigration agency has abandoned a program to develop DNA and isotope testing to assess the nationality of asylum seekers
By forging new relationships and finding novel uses for existing technologies, this year’s top companies are employing creative ways to advance their science.
Page 1 of 1